Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male Subjects

NCT02999191 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: BI 1467335 (Treatment A)
DRUG: BI 1467335 (Treatment B)
DRUG: BI 1467335 (Treatment C)

Sponsor

Boehringer Ingelheim